In a report released yesterday, from Berenberg Bank maintained a Buy rating on UCB SA, with a price target of €290.00. The company’s shares closed yesterday at €258.30.Elevate Your Investing Strategy:...
In a report released today, Charles Pitman CFA from Barclays reiterated a Buy rating on UCB SA, with a price target of €270.00. The company’s shares closed last Friday at €257.24.Elevate Your Investing...
TD Cowen analyst Stacy Ku maintained a Buy rating on UCB SA today and set a price target of €300.00. The company’s shares closed yesterday at €257.96.Elevate Your Investing Strategy: Take advantage...
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on UCB SA today and set a price target of €285.00. The company’s shares closed last Friday at €250.10.Elevate Your Investing Strategy:...
Goldman Sachs analyst Rajan Sharma reiterated a Buy rating on UCB SA on September 29 and set a price target of €255.00. The company’s shares closed yesterday at €244.62.Elevate Your Investing Strategy:...
BRUSSELS , Aug. 29, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced it will present 26 abstracts from its epilepsy portfolio at the International Epilepsy...